NCT00205751View on ClinicalTrials.gov

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

October 31, 2009

Conditions

Multiple Myeloma

Interventions

DRUG

Thalidomide/Dexamethasone vs Melphalan/Prednisone

Trial Locations (1)

1190

Wilhelminenspital, 1st Medical Department-center for oncology and hematology, Vienna

All Listed Sponsors

lead

Austrian Forum Against Cancer

OTHER

NCT00205751 - Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy | Biotech Hunter | Biotech Hunter